Literature DB >> 11136568

The role of laparoscopy in second-look evaluations for ovarian cancer.

A Husain1, D S Chi, M Prasad, N Abu-Rustum, R R Barakat, C L Brown, E A Poynor, W J Hoskins, J P Curtin.   

Abstract

BACKGROUND: The aim of this study was to evaluate the accuracy and safety of laparoscopic second-look operations in patients with ovarian cancer.
METHODS: We retrospectively reviewed the medical records of all patients who have undergone laparoscopic second-look procedures for ovarian cancer at our institution.
RESULTS: From July 1993 to December 1998, 150 patients underwent laparoscopic second-look operations. The mean age of patients was 53 years (range, 25-78 years). The majority of patients (87%) had Stage III or IV disease at initial surgery; the remainder were Stage II or unstaged. Eighty-two patients (54%) had had optimal cytoreduction at the time of their initial surgery. All patients had completed primary chemotherapy and were clinically disease-free based on imaging studies and CA-125 levels at the time of second look. Sixty-nine patients (46%) were found to have pathologically negative second looks; thus, the rate of positive second-look evaluations was 54%. The rate of conversion to laparotomy was 18/150 (12%). In 3 cases this was secondary to bowel injury; one patient sustained a bladder injury; the remainder of conversions to laparotomy were for secondary cytoreduction. There was only 1 case where the patient was found to have extensive adhesions and laparoscopy was abandoned. The overall rate of major complications was 2.7%.
CONCLUSIONS: In our experience, laparoscopy is a safe and accurate method of second-look assessment in patients with ovarian cancer. The incidence of complications is low, particularly in this group of patients, all of whom have undergone prior abdominal surgery. The rate of negative evaluations and the rate of recurrences in patients with negative second looks are equivalent to those described in studies of second-look assessment by laparotomy. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11136568     DOI: 10.1006/gyno.2000.6036

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

1.  Feasibility and accuracy of second-look laparoscopy after gastrectomy for gastric cancer.

Authors:  Kentaro Inoue; Yasushi Nakane; Taku Michiura; Sou Yamaki; Rintaro Yui; Kazuhito Sakuramoto; Aiko Iwai; Katsuji Tokuhara; Yoshiro Araki; Songtae Kim; Koji Nakai; Mutsuya Sato; Keigo Yamamichi; A-Hon Kwon
Journal:  Surg Endosc       Date:  2009-01-30       Impact factor: 4.584

2.  Use of laparoscopy as an alternative to computed tomography (CT) and positron emission tomography (PET) scans for the detection of recurrence in patients with gastric cancer: a pilot study.

Authors:  Jung Ho Shim; Han Mo Yoo; Han Hong Lee; Jun Gi Kim; Hae Myung Jeon; Kyo Young Song; Cho Hyun Park
Journal:  Surg Endosc       Date:  2011-05-02       Impact factor: 4.584

3.  Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3.

Authors:  Siqing Fu; Yanfang Li; Jie Huang; Tao Liu; Zhen Hong; Aiping Chen; Robert C Bast; John J Kavanagh; David M Gershenson; Anil K Sood; Wei Hu
Journal:  Cancer Biol Ther       Date:  2012-08-16       Impact factor: 4.742

4.  Laparoscopic cytoreduction for primary advanced ovarian cancer.

Authors:  James Fanning; Rod Hojat; Jil Johnson; Bradford Fenton
Journal:  JSLS       Date:  2010 Jan-Mar       Impact factor: 2.172

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.